These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 6202252

  • 1. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A, Sonnino-Goldman P, Leibowitz M, Dally-Meade V, Donigi-Ruzza D.
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [Abstract] [Full Text] [Related]

  • 2. Antiallergic activity profile in vitro of RHC 2963 and related compounds.
    Khandwala A, Van Inwegen R, Coutts S, Dally-Meade V, Youssefyeh RD.
    Int J Immunopharmacol; 1983 Jan; 5(6):491-502. PubMed ID: 6198298
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A, Dally-Meade V, Jariwala N, Huang F.
    Int Arch Allergy Appl Immunol; 1984 Jan; 73(1):65-70. PubMed ID: 6198288
    [Abstract] [Full Text] [Related]

  • 5. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.
    Khandwala A, Coutts S, Dally-Meade V, Jariwala N, Musser J, Brown R, Jones H, Loev B, Weinryb I.
    Biochem Pharmacol; 1983 Nov 15; 32(22):3325-33. PubMed ID: 6197075
    [Abstract] [Full Text] [Related]

  • 6. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A, Coutts S, Pruss T, Jones H, Neiss E, Weinryb I.
    Biochem Pharmacol; 1987 Mar 01; 36(5):663-72. PubMed ID: 2435293
    [Abstract] [Full Text] [Related]

  • 7. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A, Coutts SM, Dally-Meade V, Jariwala N, Huang FC.
    Int Arch Allergy Appl Immunol; 1983 Mar 01; 70(4):311-20. PubMed ID: 6186610
    [Abstract] [Full Text] [Related]

  • 8. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A, Coutts S, Weinryb I.
    Int Arch Allergy Appl Immunol; 1982 Mar 01; 69(2):159-68. PubMed ID: 6179887
    [Abstract] [Full Text] [Related]

  • 9. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
    Khandwala A, Van Inwegen R, Coutts S, Dally-Meade V, Jariwala N, Huang F, Musser J, Brown R, Loev B, Weinryb I.
    Int Arch Allergy Appl Immunol; 1984 Mar 01; 73(1):56-64. PubMed ID: 6198287
    [Abstract] [Full Text] [Related]

  • 10. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A, Coutts SM, Weinryb I.
    Int Arch Allergy Appl Immunol; 1983 Mar 01; 70(4):295-302. PubMed ID: 6186608
    [Abstract] [Full Text] [Related]

  • 11. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T, Yamamura H, Kohno S, Ohata K.
    Arerugi; 1992 Jun 01; 41(6):676-85. PubMed ID: 1280084
    [Abstract] [Full Text] [Related]

  • 12. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF, Hope WC, O'Donnell M, Baruth H, Crowley HJ, Miller DA, Yaremko B.
    J Pharmacol Exp Ther; 1984 Jan 01; 228(1):57-64. PubMed ID: 6198511
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR, Fullarton JR, Skidmore IF, Thompson LE, Vardey CJ, Wheeldon A.
    Br J Pharmacol; 1979 Sep 01; 67(1):23-32. PubMed ID: 115530
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R, Nath A, Gupta PP, Shukla M, Khare SK, Kundu B.
    Indian J Exp Biol; 2001 Sep 01; 39(9):871-7. PubMed ID: 11831367
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.
    Musser JH, Brown RE, Loev B, Bailey K, Jones H, Kahen R, Huang FC, Khandwala A, Leibowitz M, Sonnino-Goldman P.
    J Med Chem; 1984 Feb 01; 27(2):121-5. PubMed ID: 6198518
    [Abstract] [Full Text] [Related]

  • 17. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis.
    Golden HW, Crean GL, Iacuzio DA, Otterness IG.
    J Immunol; 1986 Sep 01; 137(5):1495-503. PubMed ID: 2427571
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES.
    J Med Chem; 1985 Sep 01; 28(9):1255-9. PubMed ID: 2411926
    [Abstract] [Full Text] [Related]

  • 19. Bronchodilator and antiallergic properties of LA 2851 (2-4-diamino-7-methyl-pyrazolo (1,5-a) 1,3,5-triazine).
    Junien JL, Guillaume M, Lakatos C, Sterne J.
    Arch Int Pharmacodyn Ther; 1981 Aug 01; 252(2):313-26. PubMed ID: 7305566
    [Abstract] [Full Text] [Related]

  • 20. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R, Kazimierczak W.
    Arch Immunol Ther Exp (Warsz); 1982 Aug 01; 30(5-6):333-9. PubMed ID: 6135406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.